drugset / Trial / NCT04453397
Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma
Summary
This is a single patient protocol for TNB-383B in a subject with relapsed/refractory multiple myeloma (MM) who is not a candidate for treatment regimens known to provide clinical benefit in MM.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etentamig | Monoclonal antibody | — | — |